Comprehensive Review of Pharmaceutical Advancements, Patient Care Models, and Drug Safety
Bibliographic Data
| ID | 22357474 |
|---|---|
| Authors | Sari Mohammed Alhawiti (University of Tabuk), Abdullah Salman Alatawi, Abdullah Alatawi (Ministry of Health), Naif Shayish Alsharari (Ministry of Health), Hamad Saad Albalawi (Ministry of Health), Ziyad Saleh S Alsharqawi (Ministry of Health), Amal Aydh Albaqami (Ministry of Health), Abdulaziz Saleh Albalawi (Ministry of Health), Ahmed Abdulrahman Alfaqeih (Ministry of Health), Hani Albalawi (0000-0002-3143-208X, Ministry of Health), Hani Saeed Hamoud Albalawi, Adnan Aed Baraka Alenezi (Ministry of Health) |
| Year | 2024 |
| Volume | 3 |
| Issue | 8 |
| Publication date | 2024-12-12 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ecohumanism (JOURNAL) |
| Journal identifiers | ISSN: 2752-6798 • E-ISSN: 2752-6801 |
| Publisher | Creative Publishing House (PUBLISHER • GB) |
| DOI | 10.62754/joe.v3i8.5253 |
| OpenAlex | W4405302171 |
| Language | EN |
| References cited | 1 |
This review disseminates new developments in this industry, changes in the care delivery systems, and innovations in drug safety. Pharmaceuticals have brought innovative changes within their field of drug formation, new theories regarding medicine for individuals, and introducing biotechnologies. At the same time, patient care models are changing towards the more integrated and patient-oriented ones. Further, maintaining drug safety continues to be a critical focal point because the complexity of drug therapies continues to increase, and their potential adverse effects need to be minimized. This review, therefore, looks at these interconnections based on current literature, research findings, and case studies in a bid to give an overall vision of the evolution of modern pharmaceuticals and how their advancement impacts the delivery of healthcare
Business · Drug · Engineering ethics · Health care · Healthcare delivery · Management science · Patient safety · Pharmaceutical industry · Political science · Computational Drug Discovery Methods · Engineering · Medicine · Pharmaceutical Economics and Policy · Pharmaceutical Quality and Counterfeiting · Pharmacology
| Highly cited | No |
|---|